Date: Tuesday, September 24, 2013

Time: 2:00 - 3:00 pm (Eastern Time)

Participate by Phone:

Dial In: 888-233-9077

Passcode: 3873879

Participate by Webinar:

https://www.mymeetings.com/nc/join.php?i=PW6481701&p=3873879&t=c

Presenter(s):

Renee M. Turchi, MD, MPH, FAAP
Associate Professor of Pediatrics
Drexel University College of Medicine

Henry H. Bernstein, DO, MHCM, FAAP
Professor of Pediatrics
Hofstra North Shore-LIJ School of Medicine

Seema Jain, MD
Medical Epidemiologist
Influenza Division
Centers for Disease Control and Prevention

Georgina Peacock, MD, MPH, FAAP
Medical Officer
National Center on Birth Defects and Developmental Disabilities
Centers for Disease Control and Prevention

Overview:

Children with chronic medical conditions, including asthma, diabetes, and neurologic and neurodevelopmental disorders, are at higher risk for influenza-associated complications. Using antiviral therapies early and aggressively in these vulnerable children can lessen the impact of influenza infection. Clinicians have a critical role in taking action to immunize these children and their close contacts. During this COCA Call, subject matter experts from CDC and the American Academy of Pediatrics will discuss strategies that primary care providers and medical subspecialists can use in partnership with parents to improve influenza prevention and control in children at highest risk.

Objectives:

At the conclusion of the session, the participant will be able to accomplish the following:

• Identify chronic medical conditions associated with increased risk of hospitalization or influenza complications in children.
• Review caregiver and physician perceptions and practices about seasonal influenza immunization in children with neurologic and neurodevelopmental conditions.
• Discuss collaborative opportunities for medical subspecialists and primary care pediatricians to promote medical homes for children and increase influenza immunization.
• Describe strategies and key messages to improve influenza prevention and control in children at highest risk for complications.

Click here for more information.